Related Concepts
Related Feeds
Angiogenesis Inhibitors to Treat Cancer
Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.
Cell Signaling by Tyrosine Kinases
Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.
Related Papers
Radiation Oncology
Michel ZimmermannMahmut Ozsahin
Seminars in Oncology
A Craig LockhartJordan D Berlin
Current Oncology
M Fakih, M Vincent
Molecular Cancer
Jian MaBolin Liu
Journal of Oncology
Amir HarandiDamian A Laber